List view / Grid view
The pharma industry will need to outsource manufacturing for COVID-19…
The pharma industry will need to outsource manufacturing for COVID-19 vaccine doses for booster doses and children, reports GlobalData.
A new report suggests pharma is working hard to combat…
A new report suggests pharma is working hard to combat worldwide viral vectors shortage that could threaten the COVID-19 vaccine rollout.
According to GlobalData, AstraZeneca’s and Janssen’s COVID-19 vaccines could be…
According to GlobalData, AstraZeneca’s and Janssen’s COVID-19 vaccines could be impacted by global viral vector shortages.
Reports have found that the COVID-19 pandemic is providing new…
Reports have found that the COVID-19 pandemic is providing new opportunities for contract and development manufacturing organisations (CDMOs).
A review suggests some large pharma companies were approved to…
A review suggests some large pharma companies were approved to receive paycheck protection program (PPP) loans that were intended to help small US businesses to pay workers during the COVID-19 pandemic.
According to an outlet, the in-house manufacturing of biopharma products…
According to an outlet, the in-house manufacturing of biopharma products has been threatened by the COVID-19 outbreak, especially in China.
The content sessions at CPhI Worldwide have revealed the coming…
The content sessions at CPhI Worldwide have revealed the coming trends that the pharmaceutical industry will see next year.
